يعرض 1 - 10 نتائج من 174 نتيجة بحث عن '"Dirk L. Brutsaert"', وقت الاستعلام: 0.89s تنقيح النتائج
  1. 1
    دورية أكاديمية
  2. 2

    المساهمون: CIC - HEGP (CIC 1418), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Européen Georges Pompidou [APHP] (HEGP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Paris (UP), Paris-Centre de Recherche Cardiovasculaire (PARCC (UMR_S 970/ U970)), Hôpital Européen Georges Pompidou [APHP] (HEGP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Paris (UP), Triposkiadis, Filippo, Butler, Javed, Abboud, Francois M, Armstrong, Paul W, Adamopoulos, Stamati, Atherton, John J, Backs, Johanne, Bauersachs, Johann, Burkhoff, Daniel, Bonow, Robert O, Chopra, Vijay K, de Boer, Rudolf A, de Windt, Leon, Hamdani, Nazha, Hasenfuss, Gerd, Heymans, Stephane, Hulot, Jean-Sébastien, Konstam, Marvin, Lee, Richard T, Linke, Wolfgang A, Lunde, Ida G, Lyon, Alexander R, Maack, Christoph, Mann, Douglas L, Mebazaa, Alexandre, Mentz, Robert J, Nihoyannopoulos, Petro, Papp, Zoltan, Parissis, John, Pedrazzini, Thierry, Rosano, Giuseppe, Rouleau, Jean, Seferovic, Petar M, Shah, Ajay M, Starling, Randall C, Tocchetti, Carlo G, Trochu, Jean-Noel, Thum, Thoma, Zannad, Faiez, Brutsaert, Dirk L, Segers, Vincent F, De Keulenaer, Gilles W

    المصدر: European Heart Journal
    European Heart Journal, Oxford University Press (OUP): Policy B, 2021, 40, pp.2155-2163. ⟨10.1093/eurheartj/ehz158⟩
    Eur Heart J
    European heart journal

  3. 3
  4. 4
  5. 5

    المصدر: European Journal of Heart Failure. 19:1361-1378

  6. 6
  7. 7
  8. 8

    المساهمون: Maack, Christoph, Eschenhagen, Thoma, Hamdani, Nazha, Heinzel, Frank R, Lyon, Alexander R, Manstein, Dietmar J, Metzger, Joseph, Papp, Zoltán, Tocchetti, Carlo G, Yilmaz, M Birhan, Anker, Stefan D, Balligand, Jean-Luc, Bauersachs, Johann, Brutsaert, Dirk, Carrier, Lucie, Chlopicki, Stefan, Cleland, John G, de Boer, Rudolf A, Dietl, Alexander, Fischmeister, Rodolphe, Harjola, Veli-Pekka, Heymans, Stephane, Hilfiker-Kleiner, Denise, Holzmeister, Johanne, de Keulenaer, Gille, Limongelli, Giuseppe, Linke, Wolfgang A, Lund, Lars H, Masip, Josep, Metra, Marco, Mueller, Christian, Pieske, Burkert, Ponikowski, Piotr, Ristic, Arsen, Ruschitzka, Frank, Seferovic, Petar M, Skouri, Hadi, Zimmermann, Wolfram H, Mebazaa, Alexandre, HUS Emergency Medicine and Services, University of Helsinki, Department of Diagnostics and Therapeutics, Cardiologie, MUMC+: MA Med Staf Spec Cardiologie (9), RS: Carim - H02 Cardiomyopathy, RS: CARIM - R2.02 - Cardiomyopathy, Maack, C, Eschenhagen, T, Hamdani, N, Heinzel, Fr, Lyon, Ar, Manstein, Dj, Metzger, J, Papp, Z, Tocchetti, Cg, Yilmaz, Mb, Anker, Sd, Balligand, Jl, Bauersachs, J, Brutsaert, D, Carrier, L, Chlopicki, S, Cleland, Jg, de Boer, Ra, Dietl, A, Fischmeister, R, Harjola, Vp, Heymans, S, Hilfiker-Kleiner, D, Holzmeister, J, de Keulenaer, G, Limongelli, G, Linke, Wa, Lund, Lh, Masip, J, Metra, M, Mueller, C, Pieske, B, Ponikowski, P, Ristic, A, Ruschitzka, F, Seferovic, Pm, Skouri, H, Zimmermann, Wh, Mebazaa, A, UCL - SSS/IREC/FATH - Pôle de Pharmacologie et thérapeutique, UCL - (SLuc) Service de médecine interne générale

    المصدر: European heart journal
    Eur Heart J
    European Heart Journal, 40(44), 3626-3644. Oxford University Press
    European heart journal, Vol. 40, no. 44, p. 3626-3644 (2019)

    وصف الملف: application/pdf

  9. 9

    المساهمون: BOZEC, Erwan, HOMAGE (Heart Omics in Ageing consortium) - 305507 - INCOMING, Targeting cardiac fibrosis for heart failure treatment - FIBRO-TARGETS - - EC:FP7:HEALTH2013-09-01 - 2017-08-31 - 602904 - VALID, Hepatic and Cardiac Toxicity Systems modelling - HECATOS - - EC:FP7:HEALTH2013-10-01 - 2018-09-30 - 602156 - VALID, University Medical Center Groningen [Groningen] (UMCG), University of Antwerp (UA), Hannover Medical School [Hannover] (MHH), University of Glasgow, Center for Applied Medical Research [Plamplona] (CIMA), Universidad de Navarra [Pamplona] (UNAV), Clínica Universidad de Navarra [Pamplona], Baker Heart and Diabetes Institute (AUSTRALIA), Galecto Biotech, Charité Campus Virchow-Klinikum (CVK), Charité - UniversitätsMedizin = Charité - University Hospital [Berlin], FibroGen Inc., King's College Hospital (KCH), Universidad Pública de Navarra [Espagne] = Public University of Navarra (UPNA), Navarra Institute for Health Research / Instituto de Investigación Sanitaria de Navarra (IdiSNA), Universidad Pública de Navarra [Espagne] = Public University of Navarra (UPNA)-Universidad de Navarra [Pamplona] (UNAV)-Clínica Universidad de Navarra [Pamplona], University of Oslo (UiO), Oslo University Hospital [Oslo], Royal Brompton Hospital, Orion Pharma, University of Naples Federico II = Università degli studi di Napoli Federico II, King‘s College London, University Medical Center [Utrecht], Institute of Molecular and Translational Therapeutic Strategies (IMTTS), German Center for Cardiovascular Research (DZHK), Berlin Institute of Health (BIH), Centre d'investigation clinique plurithématique Pierre Drouin [Nancy] (CIC-P), Centre d'investigation clinique [Nancy] (CIC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Défaillance Cardiovasculaire Aiguë et Chronique (DCAC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Cardiovascular and Renal Clinical Trialists [Vandoeuvre-les-Nancy] (INI-CRCT), Institut Lorrain du Coeur et des Vaisseaux Louis Mathieu [Nancy], French-Clinical Research Infrastructure Network - F-CRIN [Paris] (Cardiovascular & Renal Clinical Trialists - CRCT ), University Medical Center Göttingen (UMG), University hospital of Zurich [Zurich], University General Hospital ' Attikon ' [Athens, Greece], University of Mississippi Medical Center (UMMC), University of Würzburg = Universität Würzburg, University Hospital Wuerzburg / Universitäts­klinikum Würzburg, Maastricht University [Maastricht], Catholic University of Leuven - Katholieke Universiteit Leuven (KU Leuven), The Netherlands Heart Institute, R.A.d.B. is supported by the Netherlands Heart Foundation (CVON DOSIS, grant 2014-40, CVON SHE-PREDICTS-HF, grant 2017-21, and CVON RED-CVD, grant 2017-11), and the Innovational Research Incentives Scheme program of the Netherlands Organization for Scientific Research (NWO VIDI, grant 917.13.350). J.B. is supported is supported by the Deutsche Forschungsgemeinschaft (DFG), Clinical Research Group 311 (KFO 311) ‘(Pre)terminal heart and lung failure: unloading and repair’ (DFG, TP1, BA 1742/9-1) and ‘MR-Focus’‘ (DFG BA 1742/8-1). J.S. has received funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program (consolidator grant Evicare #725229) and by the Netherlands Heart Foundation (CVON-HUSTCARE). M.M. is a BHF Chair Holder (CH/16/3/32406), with BHF program grant support (RG/16/14/32397), and was awarded a BHF Special Project grant to participate in the ERA-CVD Translational Grant MacroERA. M.M. and T.T. are members of a network funded by the Foundation Leducq. C.G.T. is supported by a Federico II University/Ricerca di Ateneo grant. S.H. has received funding from the European Union Commission's Seventh Framework programme under grant agreement n. 305507 (HOMAGE), n. 602904 (FIBROTARGETS) and FP7-Health-2013-Innovations-1 n. 602156 (HECATOS), CVON2016-Early HFPEF, 2015-10, and CVON SHE-PREDICTS-HF, grant 2017-21. C.M. is supported by the DFG (Ma 2528/7-1, SFB 894, TRR-219) and the Federal Ministry of Education and Science (BMBF, 01EO150, CF.3, RC2)., European Project: 305507, European Project: 602904,EC:FP7:HEALTH,FP7-HEALTH-2013-INNOVATION-1,FIBRO-TARGETS(2013), European Project: 602156,EC:FP7:HEALTH,FP7-HEALTH-2013-INNOVATION-1,HECATOS(2013), de Boer, Rudolf A, De Keulenaer, Gille, Bauersachs, Johann, Brutsaert, Dirk, Cleland, John G, Diez, Javier, Du, Xiao-Jun, Ford, Paul, Heinzel, Frank R, Lipson, Kenneth E, Mcdonagh, Theresa, Lopez-Andres, Natalia, Lunde, Ida G, Lyon, Alexander R, Pollesello, Piero, Prasad, Sanjay K, Tocchetti, Carlo G, Mayr, Manuel, Sluijter, Joost P G, Thum, Thoma, Tschöpe, Carsten, Zannad, Faiez, Zimmermann, Wolfram-Hubertu, Ruschitzka, Frank, Filippatos, Gerasimo, Lindsey, Merry L, Maack, Christoph, Heymans, Stephane, Cardiologie, MUMC+: MA Med Staf Spec Cardiologie (9), RS: CARIM - R2.02 - Cardiomyopathy, RS: Carim - H02 Cardiomyopathy, University of Zurich, Cardiovascular Centre (CVC)

    المصدر: European Journal of Heart Failure
    European Journal of Heart Failure, 2019, 21 (3), pp.272-285. ⟨10.1002/ejhf.1406⟩
    European journal of heart failure
    European journal of heart failure, 21(3), 272-285. Wiley
    European Journal of Heart Failure, 21(3), 272. Oxford University Press
    European Journal of Heart Failure, 21(3), 272-285. Wiley
    Dadun. Depósito Académico Digital de la Universidad de Navarra
    Consejo Superior de Investigaciones Científicas (CSIC)

    مصطلحات موضوعية: Cardiac & Cardiovascular Systems, Fibrosi, Myocardium/metabolism, Infarction, 030204 cardiovascular system & hematology, Heart Failure/diagnosis, Imaging, Translational Research, Biomedical, 0302 clinical medicine, Fibrosis, Fibrosis/classification, Myocardial infarction, Disease management (health), Non-U.S. Gov't, 1102 Cardiorespiratory Medicine and Haematology, Translational Medical Research, Societies, Medical, Extracellular Matrix Proteins, MOLECULAR-MECHANISMS, Research Support, Non-U.S. Gov't, Cardiac Imaging Techniques/methods, Disease Management, CARDIAC FIBROBLASTS, Prognosis, 3. Good health, [SDV.MHEP.CSC] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, Europe, HFA Position Statement, PRESERVED EJECTION FRACTION, Galectin-3, 10209 Clinic for Cardiology, Cardiology, Fibroblast, DIFFUSE MYOCARDIAL FIBROSIS, INFARCTION, Cardiology and Cardiovascular Medicine, Life Sciences & Biomedicine, INTERSTITIAL FIBROSIS, Extracellular Matrix Proteins/blood, medicine.medical_specialty, Myocarditis, INHIBITION, 610 Medicine & health, Translational research, Heart failure, Research Support, 2705 Cardiology and Cardiovascular Medicine, 03 medical and health sciences, LEFT-VENTRICULAR DYSFUNCTION, [SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, Internal medicine, Medical, medicine, EXTRACELLULAR-MATRIX, Journal Article, Humans, GALECTIN-3, Science & Technology, Matrix, business.industry, Myocardium, Research, Biomarker, medicine.disease, Cardiac Imaging Techniques, Cardiovascular System & Hematology, Cardiovascular System & Cardiology, Biomarkers, Human medicine, business, Societies, Biomarkers/blood

    وصف الملف: application/pdf; pdf; Print-Electronic; image/pdf; Boer_et_al-2019-European_Journal_of_Heart_Failure.pdf - application/pdf

  10. 10
    دورية أكاديمية